Related Experiment Video
Updated: Sep 3, 2025

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Therapeutic effects of statins on osteoarthritis: A review
Shirin Saberianpour1, Samaneh Abolbashari1, Mohamad H S Modaghegh1
1Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Osteoarthritis (OA) is a progressive joint disease. The etiology of OA is considered to be multifactorial. Currently, there is no definitive treatment for OA, and the existing treatments are not very effective. Hypercholesterolemia is considered a novel risk factor for the development of OA. Statins act as a competitive inhibitor of the β-hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase and are widely used to manage hypercholesterolemia. Inhibition of HMG-CoA reductase results in reduced synthesis of a metabolite named mevalonate, thereby reducing cholesterol biosynthesis in subsequent steps. By this mechanism, statins such as atorvastatin and simvastatin could potentially have a preventive impact on joint cartilage experiencing osteoarthritic deterioration by reducing serum cholesterol levels. Atorvastatin can protect cartilage degradation following interleukin-1β-stimulation. Atorvastatin stimulates the STAT1-caspase-3 signaling pathway that was shown to be responsible for its anti-inflammatory effects on the knee joint. Simvastatin had chondroprotective effects on OA in vitro by reducing matrix metalloproteinases expression patterns. In this study, we tried to review the therapeutic effects of statins on OA.
Insights
Statins, used for high cholesterol, may prevent osteoarthritis (OA) progression. These drugs, like atorvastatin and simvastatin, show potential chondroprotective and anti-inflammatory effects in joint tissues.
Area of Science:
- Biochemistry
- Pharmacology
- Rheumatology
Background:
- Osteoarthritis (OA) is a progressive joint disease with multifactorial etiology and limited effective treatments.
- Hypercholesterolemia is an emerging risk factor for OA development.
- Statins are HMG-CoA reductase inhibitors used to manage hypercholesterolemia by reducing cholesterol synthesis.
Purpose of the Study:
- To review the potential therapeutic effects of statins on osteoarthritis.
- To explore the mechanism by which statins may impact joint cartilage health.
Main Methods:
- Literature review of studies investigating statins (atorvastatin, simvastatin) in the context of osteoarthritis.
- Analysis of in vitro and in vivo data on the effects of statins on cartilage degradation and inflammation.
Main Results:
- Statins, by inhibiting HMG-CoA reductase, reduce cholesterol biosynthesis, potentially preventing OA-related cartilage deterioration.
- Atorvastatin demonstrated cartilage protection against interleukin-1β-induced degradation and exhibited anti-inflammatory effects via the STAT1-caspase-3 pathway.
- Simvastatin showed in vitro chondroprotective effects by downregulating matrix metalloproteinases expression.
Conclusions:
- Statins possess potential preventive and therapeutic properties for osteoarthritis.
- Further research is warranted to fully elucidate the role of statins in managing OA.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
The JAK-STAT Signaling Pathway
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Skeletal Muscle Relaxants: Therapeutic Uses
Atherosclerosis IV: Nursing Management

